MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$102,755K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-100,984 -
Depreciation and amortization expense
131 -
Stock-based compensation expense
7,826 -
Net amortization of premiums and accretion of discounts on short-term investments
2,874 -
Non-cash lease expense
415 -
Accounts receivable
70 -
Prepaid expenses and other assets
7,811 -
Accounts payable
-55 -
Accrued expenses and other current liabilities
1,193 -
Operating lease liabilities
-415 -
Net cash used in operating activities
-102,644 -
Purchases of short-term investments
347,596 -
Maturities of short-term investments
195,285 -
Purchases of equipment
111 -
Net cash used in investing activities
-152,422 -
Payments of deferred offering costs
34 -
Proceeds from exercises of stock options
1,372 -
Net cash provided by financing activities
1,338 -
Restricted cash
-194
Net increase (decrease) in cash, cash equivalents and restricted cash
-253,728 -
Cash and cash equivalents
-45,458
Cash and cash equivalents at beginning of period
326,086 -
Total cash, cash equivalents and restricted cash at end of period
-45,652
Cash and cash equivalents at end of period
72,358 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Upstream Bio, Inc. (UPB)

Upstream Bio, Inc. (UPB)